Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer#39;s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|15|4|480-494

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.15, Iss.4, 2017-04, pp. : 480-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5085-5092

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's disease: Targeting the Cholinergic System

By  

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 101-115

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Foxo-Dependent Transcription by Post-Translational Modifications

By  

Current Drug Targets, Vol. 12, Iss. 9, 2011-08 ,pp. : 1303-1310

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 1, 2008-03 ,pp. : 24-29

Bentham Science Publishers

Access to resources Recommend Favorite